Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386317-113401333	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.2"	"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced					NA	NA		44000000			"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (7.33e-5)"	"prognostic favorable (5.64e-4)"	"unprognostic (4.16e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (8.80e-5)"	"unprognostic (2.87e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.31e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-2)"	19.9	70.3	24.1	6.4	26.3	27.3	13.7	14.0	24.8	8.3	10.5	28.3	8.8	11.6	7.5	11.5	14.6	6.8	13.0	23.3	24.6	20.8	29.9	84.2	8.4	5.9	37.5	20.6	12.3	18.8	24.1	7.2	10.2	27.9	14.5	10.2	9.8	37.2	15.1	10.6	15.6	10.7	8.9	40.1	5.9	18.1	5.4	28.6	4.7	10.9	6.6	7.5	9.0	8.0	7.6	12.1	19.1	13.1	5.5	9.7	7.6	3.3	5.8	4.6	6.4	32.2	22.1	29.3	9.1	15.3	6.0	7.7	8.1	7.0	4.7	5.6	12.9	4.6	12.4	3.3	6.3	3.5	11.7	4.2	9.3	7.3	10.6	7.3	8.5	8.0	18.7	4.7	5.5	2.4	23.9	11.8	7.9	3.5	7.0	9.9	24.5	9.8	8.4	2.3	24.4	11.6	7.7	8.0	8.1	9.4	7.1	4.2	4.0	11.6	14.1	8.3	8.7	14.8	9.8	12.8	5.4	4.1	10.6	5.1	10.5	9.8	3.7	15.1	7.9	5.8	7.2	11.5	19.1	9.7	13.1	5.4	5.9	8.4	5.4	12.1	7.6	8.1	8.9	5.6	5.5	12.7	4.9	8.5	7.6	24.1	26.3	14.0	24.8	24.6	20.8	37.5	20.6	27.9	28.6	14.9	14.1	10.2	9.3	6.3	12.5	50.8	17.8	10.7	9.1	14.0	25.5	36.1	11.6	14.5	4.7	12.8	25.6	70.0	23.3	18.1	9.4	7.0	13.9	55.7	15.4	4.8	8.7	12.9	16.7	6.9	10.9	10.2	11.8	5.4	13.8	5.8	15.3	28.8	13.8	42.7	14.9	6.5	9.9	6.2	7.5	8.0	9.5	6.9	16.9	6.8
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 167.6;liver: 136.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 55.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	9.2	167.6	7.8	6.7	10.6	39.1	8.9	17.0	15.4	6.0	11.0	12.0	15.3	11.4	6.3	11.8	10.5	4.7	8.7	24.8	8.8	7.0	14.1	136.4	13.5	10.0	7.6	9.9	5.8	6.1	8.5	5.8	13.4	12.2	7.3	11.1	8.3	15.7	16.9	24.6	6.8	17.4	6.5	7.3	6.3	12.2	9.7	5.0	7.5	7.4	11.4	9.6	12.1	7.6	6.8	8.4	55.0	12.2	8.8	11.3	6.3	10.3	16.1	11.4	10.5	17.8	13.3	31.0	15.2	14.1	20.4	19.8	21.4	19.6	9.7	3.8	10.6	41.4	6.1	16.3	12.5	16.7	18.8	6.4	12.4	12.7	16.2	25.2	20.1	25.0	16.5	11.7	32.4	10.8	7.5	18.6	17.0	7.3	8.0	18.5	8.4	9.5	30.7	9.8	11.9	27.9	5.7	7.1	15.3	17.9	62.7	6.0	4.0	24.6	12.1	13.7	9.6	6.9	28.7	13.3	11.4	11.3	23.5	21.9	11.9	20.5	14.6	12.7	21.9	18.1	55.0	9.2	27.8	6.9	12.2	11.3	6.8	7.2	7.7	8.4	6.0	6.5	7.0	14.2	8.8	10.2	4.8	9.7	6.3	7.8	10.6	17.0	15.4	8.8	7.0	7.6	9.9	12.2	5.0	32.8	47.6	4.5	16.4	15.3	15.1	88.4	35.7	38.8	27.3	22.7	3.9	67.2	48.0	28.5	9.7	25.9	35.4	0.0	27.6	21.7	19.9	18.1	89.4	210.5	62.6	11.1	33.3	25.2	14.6	3.1	12.4	23.3	5.0	73.9	18.6	9.1	33.4	18.7	15.6	25.9	6.8	12.9	27.3	23.7	19.0	14.2	258.6	17.3	16.1	24.3
ALAS2	ASB	ENSG00000158578	"5'-aminolevulinate synthase 2"	P22557	X	55009055-55031064	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 130.9;placenta: 53.5"	"Cell type enriched"	"Detected in some"	86	"Erythroid cells: 1168.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 2.0"	"Group enriched"	"Detected in some"	87	"HEL: 32.8;K-562: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"	NA	NA						"unprognostic (7.82e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	1.7	0.4	0.8	0.4	0.8	130.9	0.5	0.2	0.5	0.3	0.4	0.5	0.0	0.4	0.3	0.3	2.3	1.0	0.5	2.9	0.7	0.7	1.6	2.4	17.3	0.3	1.3	0.7	6.1	2.3	0.3	1.0	53.5	2.3	2.6	0.3	1.0	0.5	0.3	3.7	0.4	0.4	1.1	0.9	22.3	0.3	0.5	0.0	0.4	3.2	0.0	0.3	7.0	6.5	0.3	2.0	0.3	0.1	0.0	0.3	10.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	32.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	2.0	0.0	10.7	0.8	0.8	0.2	0.5	0.7	0.7	1.3	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0	1168.1	0.2	0.6	0.2	0.0	0.0	0.8	1.9	0.0	1.7	0.0	1.3	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 210.4;monocytes: 171.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		NA	NA		1600000	Cytosol		"HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450"	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	31.7	13.1	14.5	16.2	14.7	23.8	22.5	13.3	21.9	22.7	25.9	9.1	12.6	5.2	19.3	58.7	35.8	18.7	17.5	21.7	11.9	16.2	26.8	6.0	27.7	25.1	15.8	15.4	26.4	14.8	19.3	13.1	12.2	20.5	21.8	8.8	17.2	17.9	21.1	23.0	15.1	12.2	26.4	10.6	40.9	17.7	9.3	6.7	12.1	19.0	21.3	21.5	28.5	18.9	4.9	23.2	27.5	61.6	3.4	14.0	30.7	11.3	22.0	6.4	26.7	13.7	18.3	0.3	7.7	23.9	13.2	16.2	5.2	6.8	0.0	14.9	12.2	46.9	14.9	19.6	19.5	11.3	53.1	13.7	24.4	20.3	32.2	35.0	2.7	9.2	12.4	33.1	13.9	9.3	26.7	22.4	12.3	16.1	13.5	10.0	12.2	8.4	1.4	8.7	2.5	25.4	18.8	11.1	61.4	29.3	6.3	8.3	25.6	15.8	15.8	12.8	11.8	35.5	18.3	13.6	12.2	13.5	5.3	13.1	18.3	14.4	0.0	19.9	11.0	18.9	7.8	50.5	27.5	7.0	61.6	6.6	4.9	14.0	11.7	23.2	2.4	7.5	5.8	4.5	3.4	57.7	3.4	13.6	30.7	14.5	14.7	13.3	21.9	11.9	16.2	15.8	15.4	20.5	6.7	56.6	76.2	9.0	49.2	25.8	17.0	52.9	12.7	76.3	62.6	33.2	2.0	8.3	48.0	45.9	0.6	26.4	1.3	46.7	30.3	8.7	33.7	33.1	108.6	0.9	210.4	7.9	0.0	24.5	107.5	1.3	34.2	72.6	43.9	171.3	0.0	19.3	29.9	0.0	27.3	86.5	11.5	45.3	49.2	2.6	3.8	30.1	4.3	25.0	0.4	35.9
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465840	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.6"	"Cell type enhanced"	"Detected in all"	13	"Erythroid cells: 2523.0;Hofbauer cells: 895.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 73.4"	"Group enriched"	"Detected in all"	7	"dendritic cells: 54.8;monocytes: 73.4"	"Cell line enhanced"	"Detected in many"		"A549: 81.2;K-562: 73.7;OE19: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		440000000	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	36.9	17.9	10.9	12.8	12.2	137.6	28.9	3.5	10.9	17.0	26.7	7.7	18.5	20.9	14.1	19.6	45.3	14.6	19.0	31.0	8.2	8.6	31.8	72.4	37.3	30.0	11.7	9.6	21.3	19.4	5.7	5.6	32.2	13.8	22.9	7.7	17.5	27.1	22.1	43.4	16.7	26.4	22.1	9.7	47.1	31.1	7.6	7.9	6.6	24.3	42.9	24.4	29.9	22.1	8.6	54.8	9.1	73.4	4.0	5.3	34.4	34.2	81.2	1.1	12.1	11.3	10.9	9.6	4.3	12.7	5.9	11.5	15.9	31.1	11.5	33.5	7.7	19.2	11.0	4.1	9.4	1.2	19.5	3.5	17.5	12.2	9.6	26.1	0.2	5.1	10.6	17.9	7.9	4.4	6.0	6.2	4.3	73.7	20.9	6.9	53.2	0.9	1.0	0.3	64.3	22.7	8.1	3.8	18.6	7.4	23.1	0.0	1.8	13.1	34.7	13.2	1.6	33.7	2.6	6.7	15.8	16.9	24.2	2.3	11.4	13.4	4.3	41.1	6.9	6.1	5.0	73.4	2.6	4.6	33.7	4.4	8.6	4.0	4.0	54.8	5.4	4.2	3.3	9.1	4.0	16.9	11.5	5.3	34.4	10.9	12.2	3.5	10.9	8.2	8.6	11.7	9.6	13.8	7.9	205.4	126.9	50.2	283.1	114.9	10.9	116.8	180.9	95.0	73.9	92.5	5.9	76.7	225.5	197.9	7.2	54.2	483.6	2523.0	231.2	82.2	103.0	212.9	41.6	520.7	895.0	9.5	43.0	55.9	549.4	16.6	115.1	152.9	136.7	94.6	130.3	62.8	228.4	480.5	88.4	302.1	11.3	32.3	73.1	2.1	3.6	114.0	62.5	43.7	144.8	253.2
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149222055	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 311.1"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 505.9;Club cells: 754.1;Hepatocytes: 1101.0;Muller glia cells: 606.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"EFO-21: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	830000000000			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	1.8	0.7	2.6	0.6	5.7	0.4	3.5	2.6	3.5	10.5	2.0	2.5	0.0	1.7	2.3	0.3	1.1	1.5	0.5	6.6	3.6	1.7	1.6	311.1	2.1	2.4	4.2	0.9	0.4	1.2	1.4	5.3	1.9	9.4	2.1	2.7	15.5	6.9	0.4	1.2	2.0	2.6	0.7	4.8	3.5	0.7	0.5	4.4	0.0	2.8	0.4	3.0	3.2	2.9	1.3	0.8	0.6	1.0	0.3	1.3	0.4	0.0	4.9	4.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.2	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.1	1.8	4.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.5	0.8	0.6	0.8	0.9	0.4	0.5	0.6	1.3	0.4	1.3	0.4	0.3	0.4	0.8	0.4	0.4	2.6	5.7	2.6	3.5	3.6	1.7	4.2	0.9	9.4	4.4	17.9	59.9	35.0	6.7	3.0	6.0	0.4	86.6	505.9	754.1	8.7	5.9	0.0	0.0	26.9	0.5	5.3	0.0	93.5	17.8	0.2	12.7	23.8	2.3	1101.0	0.6	4.8	0.0	42.4	37.9	0.4	0.3	3.4	0.0	2.8	0.0	606.4	111.7	0.0	0.4	0.1	13.8	0.0	2.6	0.0	0.0	2.3	0.2	4.3	0.0	44.8
CPNE7		ENSG00000178773	"Copine 7"	Q9UBL6	16	89575768-89597246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.5;epididymis: 26.2;seminal vesicle: 21.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 12.4;Collecting duct cells: 19.2;Spermatogonia: 7.5;T-cells: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 42.8;TIME: 23.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043359	Uncertain					NA	NA					"HPA043359: AB_10794884"	"unprognostic (6.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (9.52e-6)"	"unprognostic (1.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (7.22e-4)"	0.4	0.9	9.5	1.4	6.4	1.3	1.6	0.0	14.2	1.7	0.8	3.3	34.5	4.8	0.9	26.2	1.6	1.6	4.4	0.7	8.0	14.6	3.3	0.9	1.4	0.9	4.0	9.3	0.7	1.1	0.8	11.0	0.6	4.1	1.9	0.4	0.7	2.0	21.9	0.2	2.3	2.8	0.5	0.7	1.0	4.5	2.7	1.0	1.7	0.6	0.0	0.8	1.4	0.8	0.0	0.0	0.2	0.0	1.2	8.5	0.4	0.0	9.8	0.1	0.1	16.8	17.4	0.1	4.2	1.8	6.0	4.6	9.8	8.2	0.0	3.8	1.6	0.2	6.6	6.2	0.2	2.0	2.3	4.8	0.1	7.3	0.1	42.8	0.0	1.6	6.8	0.4	3.1	11.8	20.0	0.1	6.9	10.3	0.1	14.1	1.4	3.0	1.8	6.4	6.0	7.6	0.1	0.0	6.7	0.8	0.0	5.5	0.0	1.4	2.0	0.4	0.1	1.8	1.2	23.2	11.6	0.0	7.1	0.0	0.0	0.0	1.8	11.4	6.7	4.7	0.0	0.0	0.2	1.1	0.0	8.5	0.0	2.0	3.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.3	0.4	9.5	6.4	0.0	14.2	8.0	14.6	4.0	9.3	4.1	1.0	0.0	1.1	0.0	0.8	2.1	12.4	0.8	2.5	0.0	1.2	19.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.0	1.7	0.0	0.0	0.1	0.3	0.0	0.7	1.3	0.9	0.0	0.5	0.2	7.5	1.0	0.0	5.7	0.1	1.3
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98521132-98593723	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 140.2;Extravillous trophoblasts: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Enhanced	Mitochondria		No	No		140000	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	6.6	8.9	12.6	9.0	29.9	30.2	6.6	10.1	21.1	7.5	8.2	29.6	5.7	17.7	8.8	6.4	14.1	6.4	7.2	6.9	17.5	11.7	5.6	29.3	6.3	9.1	42.9	16.2	9.5	6.9	9.9	5.5	14.8	23.7	7.4	10.3	3.4	7.2	7.2	8.5	10.8	12.3	7.7	32.8	9.1	7.7	3.9	36.0	7.7	6.2	7.0	9.8	8.5	10.4	1.7	1.7	0.0	2.1	2.1	3.0	0.7	16.6	8.1	7.2	12.7	13.5	10.0	20.7	10.8	7.8	11.1	12.7	13.4	5.2	1.7	12.1	5.7	12.3	12.1	8.9	11.6	19.0	5.3	7.8	58.1	4.6	17.3	6.9	12.2	13.8	7.8	9.8	10.5	4.4	13.1	10.6	7.2	11.1	7.5	10.4	5.1	12.3	10.5	8.5	9.3	14.8	8.8	16.4	7.7	9.4	6.9	4.8	4.7	11.4	3.9	32.3	8.4	6.1	7.9	8.8	16.6	16.3	9.5	7.8	11.6	9.1	9.4	16.5	13.5	12.1	0.0	2.1	0.0	1.4	1.0	2.5	1.7	2.4	2.9	1.7	1.5	0.8	3.0	0.0	2.1	0.7	1.1	1.1	0.7	12.6	29.9	10.1	21.1	17.5	11.7	42.9	16.2	23.7	36.0	3.0	8.3	6.9	4.0	6.5	3.4	7.1	2.5	1.4	0.0	3.5	7.9	21.7	1.7	3.0	0.0	5.8	6.4	140.2	1.6	67.8	9.9	4.4	1.1	30.1	11.2	0.0	8.1	11.6	10.8	0.0	6.9	8.9	11.8	10.8	8.6	6.0	2.8	0.0	7.4	5.1	5.3	12.9	9.0	0.0	3.2	8.9	8.9	10.7	9.7	3.7
CYBRD1	"CYB561A2, DCYTB, FLJ23462, FRRS3"	ENSG00000071967	"Cytochrome b reductase 1"	Q53TN4	2	171522247-171558133	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 205.4;Leydig cells: 187.0;Peritubular cells: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.0;intermediate monocyte: 12.4;myeloid DC: 11.7;neutrophil: 6.7;non-classical monocyte: 9.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 11.7;granulocytes: 6.7;monocytes: 12.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 144.2;ASC TERT1: 62.7;BJ hTERT+: 54.3;HSkMC: 44.4;hTERT-RPE1: 37.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014757	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014757: AB_1847374"	"unprognostic (1.35e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.44e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-2)"	75.2	26.0	10.1	9.3	13.2	4.0	78.9	6.1	8.0	44.5	56.3	14.7	16.3	49.5	44.3	28.5	29.6	26.1	38.8	43.1	12.1	5.5	8.6	6.2	35.6	10.6	11.0	11.2	49.5	5.4	2.0	9.5	9.5	11.4	41.7	10.2	32.0	21.5	21.1	17.5	26.7	111.3	41.1	12.8	7.3	18.1	20.1	11.7	2.1	103.8	23.9	10.0	43.8	56.0	0.0	11.7	6.7	12.4	2.5	1.2	4.4	3.2	2.4	1.3	2.6	144.2	62.7	0.2	11.8	54.3	6.2	7.8	0.1	4.5	0.0	2.0	27.7	6.3	1.6	1.1	0.9	7.3	2.4	0.3	2.7	3.7	0.0	30.3	2.8	0.2	44.4	9.2	9.6	1.8	37.0	3.9	1.6	0.9	0.0	16.9	0.0	0.9	2.6	0.7	0.0	0.6	0.3	17.0	0.1	0.9	0.1	0.1	0.6	13.7	0.0	7.3	0.5	4.8	1.7	7.8	13.9	2.0	12.9	5.0	0.0	0.0	0.0	6.6	2.4	7.4	0.0	12.0	0.5	1.2	12.4	0.2	0.0	0.2	0.1	11.7	0.0	0.0	0.0	6.7	2.5	9.4	0.5	0.0	4.4	10.1	13.2	6.1	8.0	12.1	5.5	11.0	11.2	11.4	11.7	205.4	82.9	0.0	33.8	107.6	0.0	17.1	28.1	8.1	48.9	24.4	0.0	1.6	0.0	1.0	0.9	40.3	13.6	46.7	5.8	1.3	122.8	21.6	2.3	2.1	39.6	0.0	0.0	57.7	57.5	2.1	187.0	28.5	42.2	12.6	3.8	29.3	1.3	8.6	208.2	0.3	1.8	19.4	57.5	0.9	1.3	52.6	1.1	2.5	4.8	13.8
FECH		ENSG00000066926	Ferrochelatase	P22830	18	57548283-57586772	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 87.9"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 132.6;Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044100, HPA048177"	Approved					NA	NA					"HPA044100: AB_2678809, HPA048177: AB_2680300"	"unprognostic (2.30e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.85e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"prognostic favorable (2.38e-10)"	"unprognostic (1.10e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.05e-3)"	"unprognostic (3.58e-2)"	10.0	18.0	9.9	6.5	14.1	87.9	9.9	7.9	17.4	7.9	9.5	23.1	8.0	7.6	10.5	7.9	13.6	8.5	6.9	17.6	10.4	9.7	28.2	28.3	7.2	9.8	12.0	13.9	9.1	9.5	11.4	8.8	14.8	15.6	14.5	9.3	12.1	10.1	11.1	36.2	8.6	7.2	12.3	11.7	10.6	8.5	5.8	13.1	18.4	11.6	10.8	7.1	12.1	8.8	4.2	12.4	14.9	10.9	13.8	9.3	9.1	7.4	20.3	7.4	12.0	4.8	10.9	13.2	10.6	10.9	15.4	13.8	5.4	6.8	3.3	10.9	14.5	8.0	9.5	11.0	8.9	12.4	19.4	11.7	24.6	14.1	11.1	12.3	17.1	44.9	11.3	9.5	9.5	4.4	8.3	11.5	20.7	34.9	14.0	8.6	8.8	17.8	3.6	5.6	4.3	8.8	12.8	10.4	20.0	15.3	14.0	7.5	11.3	13.7	14.8	6.2	6.9	14.1	7.2	9.1	5.4	7.1	2.1	7.7	41.1	17.6	7.2	8.7	8.4	9.0	14.0	9.6	14.9	9.3	10.9	6.7	4.2	5.7	8.3	12.4	2.6	4.2	5.9	0.7	13.8	10.2	9.5	5.9	9.1	9.9	14.1	7.9	17.4	10.4	9.7	12.0	13.9	15.6	13.1	6.0	8.8	5.2	4.9	2.3	3.7	19.8	20.4	9.4	5.7	5.2	3.9	32.2	132.6	15.0	0.4	6.0	5.9	210.2	14.3	16.4	10.4	5.2	16.1	22.9	28.7	7.9	2.4	3.1	6.1	0.7	9.2	10.0	1.7	19.8	3.6	15.1	10.4	5.1	6.7	11.3	4.2	0.0	5.1	2.6	3.8	2.8	20.3	8.3	5.6	3.1
FTH1	"FHC, FTH, FTHL6, PIG15, PLIF"	ENSG00000167996	"Ferritin heavy chain 1"	P02794	11	61959718-61967660	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 756.2"	"Cell type enhanced"	"Detected in all"	9	"monocytes: 52379.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 756.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 555.5;HHSteC: 578.8"	"Low region specificity"	"Detected in all"							CAB008623	Approved		Approved	Microtubules		NA	NA		9000000	Microtubules		"CAB008623: "	"unprognostic (7.15e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (2.99e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.83e-2)"	155.1	118.0	177.6	138.9	92.6	162.0	302.9	38.5	163.7	104.2	142.4	97.8	72.0	72.2	81.6	102.4	88.8	70.6	83.5	236.1	124.7	91.2	113.5	128.2	297.3	394.0	118.5	110.6	81.7	150.8	49.7	46.7	70.1	77.5	60.9	138.5	79.5	180.5	65.1	124.1	42.5	110.0	140.0	182.1	84.4	81.0	67.8	88.2	58.5	100.3	64.1	48.9	106.7	94.0	69.5	163.3	756.2	424.5	30.7	69.2	284.2	65.4	183.8	28.0	74.1	555.5	269.1	154.7	60.1	258.0	61.3	61.9	22.2	90.9	7.6	381.6	172.8	234.7	112.1	25.0	49.7	39.8	31.2	12.3	38.1	254.7	145.1	578.8	17.8	59.9	364.4	244.0	122.3	230.1	194.4	76.7	44.1	56.7	87.4	214.0	88.5	20.0	29.2	47.9	229.9	310.8	19.9	34.6	54.5	313.4	178.2	23.8	30.2	206.4	22.7	97.7	96.5	40.4	24.1	85.4	191.7	45.9	84.8	37.7	15.1	52.0	23.4	261.3	8.0	45.6	401.9	297.7	247.4	40.8	367.6	40.2	68.6	58.3	40.4	163.3	69.5	49.3	38.2	756.2	30.7	424.5	121.2	69.2	284.2	177.6	92.6	38.5	163.7	124.7	91.2	118.5	110.6	77.5	88.2	1223.8	3688.2	1741.3	6882.7	4581.6	811.0	10.8	4076.4	2049.0	1899.5	1819.7	540.0	3704.8	9226.3	8116.7	214.1	3238.4	10084.1	4345.2	9486.9	4714.1	4023.6	8092.3	6278.5	3801.3	17699.0	697.6	2425.9	2794.1	10131.9	335.0	4320.5	19898.9	6750.0	52379.0	4287.5	3515.6	10476.1	8248.3	3589.2	14886.0	2120.1	2050.2	6618.7	591.9	960.7	3108.0	3865.9	1625.8	5251.4	8218.4
FTMT	MtF	ENSG00000181867	"Ferritin mitochondrial"	Q8N4E7	5	121851955-121852833	"Enzymes, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"testis: 68.0"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 604.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	4	"HDLM-2: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																				"unprognostic (4.39e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	604.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.6	2.4	0.0	0.0	0.0	0.0	0.0
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035259-69120427	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	8.7	19.9	10.8	9.1	9.8	21.9	11.8	13.9	11.0	8.3	9.3	12.3	11.6	6.6	12.4	11.7	9.2	9.6	7.2	20.2	8.7	10.1	10.2	40.2	9.5	12.8	11.7	8.5	16.8	25.9	18.8	8.6	8.4	10.5	9.9	11.6	12.1	11.9	13.6	25.1	5.2	7.2	16.6	8.9	12.9	9.2	13.3	9.7	3.7	11.1	9.5	9.6	10.5	7.9	15.8	17.7	2.0	18.5	24.2	28.3	19.1	11.3	9.6	15.8	7.6	7.2	10.7	15.3	8.2	7.3	12.6	9.7	5.1	7.4	20.4	6.4	8.5	13.0	12.4	18.6	18.8	15.9	23.8	21.3	28.6	6.3	37.8	12.4	20.9	12.5	11.9	15.2	12.6	13.7	4.5	16.8	12.6	21.5	20.0	11.6	11.1	5.9	9.2	21.3	23.1	19.2	14.1	10.8	13.9	14.5	9.4	12.2	5.5	8.4	5.5	8.6	11.6	6.2	6.5	10.0	8.3	14.4	10.8	11.9	5.6	4.8	12.1	3.9	17.3	8.2	2.0	16.7	0.1	21.5	18.5	16.3	15.8	22.0	21.2	17.7	10.3	28.3	27.1	0.8	24.2	14.1	15.0	17.0	19.1	10.8	9.8	13.9	11.0	8.7	10.1	11.7	8.5	10.5	9.7	3.0	11.5	20.6	17.3	8.7	6.2	39.9	7.6	5.3	3.4	14.0	3.9	35.6	18.3	16.1	2.0	11.7	3.1	0.0	12.7	16.7	14.6	12.0	6.9	60.1	30.0	0.0	6.9	8.0	14.6	4.6	14.7	15.5	16.9	14.4	11.5	8.3	15.0	0.0	12.4	20.7	1.0	12.9	17.6	3.8	31.7	7.0	12.2	13.1	15.6	11.9
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123078	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavorable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	10.6	14.2	8.8	9.0	12.7	11.8	9.6	11.0	17.7	6.7	15.5	7.4	8.0	17.2	8.5	5.5	15.8	6.9	9.8	36.9	8.4	8.3	15.9	19.0	9.5	10.1	8.2	11.1	10.0	11.4	11.5	10.0	12.8	10.6	7.8	15.2	9.3	12.8	8.0	41.6	13.8	14.4	10.4	6.3	12.3	12.2	10.5	6.0	10.3	10.8	16.4	11.8	11.4	17.3	18.1	28.4	13.3	29.7	8.4	11.1	8.7	23.2	26.7	12.5	12.0	11.8	11.4	13.3	23.4	17.9	29.6	25.4	31.0	17.0	14.4	12.1	18.8	33.0	21.6	25.9	22.4	29.0	13.5	20.3	14.5	34.3	15.4	20.9	15.7	17.7	11.1	17.5	28.2	19.3	16.0	21.0	11.1	26.8	16.8	19.9	31.5	11.4	12.8	22.7	14.1	29.0	11.2	25.1	28.4	19.9	18.3	9.0	10.7	23.4	25.5	15.0	27.6	19.7	11.4	20.6	19.2	10.4	49.2	19.9	12.3	12.6	19.2	15.5	12.7	18.4	10.1	22.5	13.3	9.9	29.7	9.5	18.1	9.7	8.9	28.4	15.5	8.5	11.1	6.2	8.4	24.8	25.9	10.4	8.7	8.8	12.7	11.0	17.7	8.4	8.3	8.2	11.1	10.6	6.0	6.0	4.5	22.9	41.8	48.7	5.1	47.6	20.4	16.0	15.9	15.7	0.0	29.4	43.1	32.7	3.8	15.8	37.0	23.3	25.6	30.7	17.7	30.5	12.7	15.3	36.7	7.9	10.4	12.3	22.9	1.3	12.4	23.8	23.6	31.5	20.2	8.7	46.3	31.6	9.9	30.7	7.1	6.5	25.0	13.4	25.4	40.3	34.2	13.8	28.1	88.7
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.2"	"Cell type enriched"	"Detected in many"	16	"Erythroid cells: 794.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		NA	NA		28000000	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: AB_2681206"	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	5.5	11.0	5.3	6.2	9.3	75.2	8.6	5.2	8.0	5.5	8.3	6.0	6.0	7.9	6.9	7.9	9.4	5.5	6.4	11.5	5.9	5.5	9.9	22.2	5.8	14.5	8.8	4.5	3.7	21.2	7.9	5.9	9.7	8.4	5.5	9.2	4.1	10.1	7.2	17.4	6.0	7.9	6.8	9.7	10.4	7.1	7.4	7.5	6.0	8.4	13.0	9.3	5.7	4.8	7.7	19.1	12.0	14.0	3.8	7.4	9.4	9.2	14.1	6.8	12.0	5.4	6.8	10.2	7.4	8.3	10.9	9.4	17.5	14.7	14.3	16.6	9.4	10.3	13.2	10.1	14.4	7.0	9.8	10.4	23.6	5.7	12.8	10.1	8.8	7.7	7.4	9.2	17.2	13.2	4.8	5.0	13.5	34.9	6.4	8.6	37.2	8.5	17.0	7.6	17.1	9.0	9.9	6.7	14.0	11.0	8.5	7.5	10.2	5.9	9.3	6.5	5.1	15.9	12.2	4.7	8.3	6.3	8.1	8.6	3.5	4.1	8.5	5.5	11.6	9.8	12.0	14.0	1.4	5.1	12.2	6.7	7.7	4.8	5.7	19.1	7.2	7.4	5.6	0.4	3.8	7.3	12.3	4.9	9.4	5.3	9.3	5.2	8.0	5.9	5.5	8.8	4.5	8.4	7.5	8.9	7.0	9.3	7.6	7.0	4.7	12.6	7.6	10.7	4.5	10.4	25.5	50.1	16.6	18.3	1.2	4.9	8.5	794.3	27.0	50.5	8.4	10.8	2.3	20.2	25.6	9.5	12.7	6.7	10.8	1.8	5.5	10.1	13.5	15.4	15.5	5.7	19.8	8.6	8.1	18.1	24.3	0.0	8.2	1.1	24.4	7.0	19.5	4.1	27.6	5.9
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 209.8"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 439.8;Kupffer cells: 915.4;monocytes: 247.9;Syncytiotrophoblasts: 419.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4"	"Lineage enriched"	"Detected in many"	6	"monocytes: 53.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 108.8;GAMG: 71.3;U-138 MG: 63.5;U-87 MG: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA		17000	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	28.4	10.3	4.1	12.5	8.7	16.3	13.8	0.8	20.6	5.7	12.0	6.1	0.6	22.0	2.5	8.5	8.8	9.8	9.8	10.2	4.1	3.1	23.0	63.7	54.0	76.3	12.5	1.3	28.6	8.8	0.5	2.7	21.1	7.5	3.6	4.9	3.3	3.5	0.8	21.9	13.8	22.8	6.9	11.2	209.8	4.6	5.9	7.6	3.6	4.2	7.3	8.3	6.7	10.2	4.8	7.9	8.4	53.4	1.1	0.3	10.1	1.4	22.1	0.2	4.5	18.1	5.3	108.8	10.2	6.0	4.8	5.2	9.8	1.3	0.0	2.3	8.3	71.3	1.2	1.3	0.2	1.5	36.6	1.1	0.5	6.7	20.0	25.2	1.3	6.9	16.6	0.4	31.7	2.1	7.7	14.4	0.0	0.0	10.6	15.3	1.1	0.0	0.5	2.2	13.6	2.5	0.1	1.9	3.4	3.4	11.9	0.3	0.3	26.4	2.3	1.7	9.6	1.0	0.3	5.4	63.5	2.8	10.3	9.9	6.6	8.5	1.0	61.6	0.6	1.0	2.0	17.7	1.2	0.2	40.5	0.0	4.8	0.1	0.3	7.9	0.5	0.0	0.0	8.4	1.1	53.4	0.2	0.2	10.1	4.1	8.7	0.8	4.8	4.1	3.1	12.5	1.3	7.5	7.6	3.0	21.3	13.8	5.9	14.5	0.0	3.1	10.2	1.4	0.0	5.2	0.0	39.4	18.3	10.3	1.6	20.2	43.4	0.0	1.3	204.4	21.6	85.9	11.5	19.5	439.8	0.0	15.3	30.7	915.4	1.3	28.7	175.5	33.7	247.9	5.3	0.2	8.7	10.5	4.9	128.1	0.4	0.0	16.5	0.9	2.7	13.7	419.8	10.0	4.1	91.1
HMOX2	HO-2	ENSG00000103415	"Heme oxygenase 2"	P30519	16	4474690-4510347	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 438.7;Late spermatids: 1517.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025464, HPA040611"	Supported		Approved	Vesicles,Cytosol		NA	NA		1200000	"Vesicles, Cytosol"		"CAB025464: , HPA040611: AB_10961034"	"unprognostic (3.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (2.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (9.87e-2)"	"prognostic favorable (8.98e-6)"	"unprognostic (3.51e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.64e-1)"	19.4	19.2	32.1	15.7	50.7	13.6	16.6	19.7	38.6	13.3	17.9	22.9	12.2	23.5	11.9	18.7	36.6	15.6	19.7	57.2	29.3	22.0	32.2	39.7	15.8	20.8	27.3	35.1	12.5	22.4	20.6	14.7	12.5	36.5	12.1	19.9	8.6	16.0	10.0	20.1	16.6	19.3	16.6	27.2	23.3	29.7	48.1	28.2	8.7	13.8	16.7	25.3	16.5	15.0	14.5	14.5	48.7	8.9	18.7	35.8	25.8	24.9	10.7	6.3	13.8	19.1	9.8	10.6	17.3	8.5	14.7	12.8	13.5	17.0	11.6	19.4	15.8	10.3	15.2	20.0	37.0	16.7	14.8	13.6	8.4	10.3	18.3	12.9	18.2	14.4	15.3	12.4	17.0	12.5	12.3	26.9	14.0	13.6	5.9	13.5	31.0	15.0	14.3	9.7	24.1	10.1	16.0	11.2	24.3	20.4	16.5	10.8	6.3	13.8	29.3	18.6	12.6	18.2	10.2	26.3	8.3	12.3	35.6	8.8	7.3	9.0	25.6	5.3	15.1	10.5	13.7	7.4	48.7	35.2	8.9	29.9	14.5	32.7	35.8	14.5	13.0	31.7	32.7	26.1	18.7	6.5	8.2	30.0	25.8	32.1	50.7	19.7	38.6	29.3	22.0	27.3	35.1	36.5	28.2	32.8	46.9	52.0	27.0	48.7	27.1	59.3	33.1	30.8	38.7	34.9	19.6	64.6	109.5	72.8	438.7	41.7	76.2	0.0	78.6	57.9	43.8	31.4	19.6	78.8	59.5	27.0	30.5	66.3	24.7	1517.1	42.0	39.8	59.1	33.3	27.6	51.0	91.4	52.6	52.6	178.2	20.2	71.1	77.6	151.1	90.1	45.0	32.2	90.0	41.2	25.1
HPS3	"BLOC2S1, SUTAL"	ENSG00000163755	"HPS3, biogenesis of lysosomal organelles complex 2 subunit 1"	Q969F9	3	149129584-149173732	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Albinism, Disease mutation, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046281, HPA052778"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"		"HPA046281: AB_10961641, HPA052778: AB_2681943"	"unprognostic (1.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.06e-2)"	14.4	17.6	10.5	16.1	11.5	6.3	18.8	8.1	11.8	13.0	11.7	12.8	6.2	13.7	17.1	10.3	10.2	12.4	11.5	8.9	9.9	8.7	15.3	10.1	12.1	25.1	11.5	10.4	18.7	13.8	10.1	11.8	13.3	11.9	13.4	11.8	13.9	13.4	11.5	5.9	8.9	16.3	13.4	17.1	19.8	12.5	8.5	12.6	23.8	13.7	4.5	19.9	16.3	17.9	16.3	19.9	16.1	15.4	9.3	16.0	10.7	19.8	11.0	6.6	6.8	9.3	12.0	5.0	8.2	16.1	10.8	14.0	3.7	13.2	5.1	10.5	9.8	49.5	6.8	7.3	5.6	14.0	12.4	5.8	2.3	5.3	4.1	8.3	6.3	3.9	7.8	5.7	10.4	4.3	22.2	11.0	8.4	2.6	12.4	13.7	12.3	4.5	8.9	15.9	10.8	8.9	5.4	4.3	13.6	5.9	10.0	2.0	5.3	7.0	7.5	15.2	15.0	8.1	8.4	5.5	10.8	1.9	10.9	11.8	10.2	4.0	12.6	16.1	12.4	2.6	16.1	12.8	11.9	13.4	15.4	16.0	16.3	12.2	13.8	19.9	13.3	9.5	12.5	5.8	9.3	10.1	11.3	10.5	10.7	10.5	11.5	8.1	11.8	9.9	8.7	11.5	10.4	11.9	12.6	11.9	15.0	15.9	4.2	3.3	6.4	2.0	5.1	24.1	30.7	7.0	2.0	20.2	5.0	9.2	2.4	7.7	8.4	0.0	15.5	11.9	8.0	7.2	15.0	6.7	18.3	3.2	8.6	20.3	25.2	2.6	10.6	17.8	13.5	3.6	8.6	26.3	10.6	3.5	28.3	18.9	5.0	0.0	5.1	2.6	9.3	4.5	11.8	20.0	6.0	4.4
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166410-161178013	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030123	Uncertain		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"HPA030123: AB_10603987"	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	7.3	14.8	11.6	9.1	12.1	31.7	10.2	23.5	16.5	11.0	9.9	13.2	8.5	6.0	11.7	13.5	7.5	33.2	9.5	9.5	11.5	12.5	12.0	9.1	10.2	11.2	14.2	16.1	13.0	13.1	10.5	12.3	10.1	12.1	11.0	6.7	14.4	11.3	14.6	8.5	15.9	7.1	10.0	10.6	12.0	8.2	6.9	13.7	9.2	11.0	6.1	8.7	8.7	8.2	9.8	11.5	6.9	7.7	12.3	16.7	8.9	7.1	6.6	9.9	6.4	7.5	8.0	3.3	4.9	5.7	6.1	8.1	7.7	6.9	5.6	11.9	3.4	3.1	4.9	7.6	7.9	5.5	3.9	15.0	6.7	14.8	17.6	8.0	2.2	3.7	6.4	8.0	5.9	8.4	9.2	11.5	5.2	19.9	8.7	4.4	6.7	8.9	7.1	7.1	9.0	14.1	10.9	6.8	13.2	11.6	3.1	7.8	12.7	6.0	8.7	9.9	12.5	15.8	10.5	4.0	5.6	6.2	4.9	6.3	15.5	11.3	8.6	5.7	4.9	4.3	6.9	7.7	5.5	12.7	7.7	8.4	9.8	9.8	8.8	11.5	8.6	8.6	8.8	1.6	12.3	5.3	7.2	16.7	8.9	11.6	12.1	23.5	16.5	11.5	12.5	14.2	16.1	12.1	13.7	3.0	13.6	4.5	7.2	10.6	16.2	7.7	7.6	62.9	13.6	7.0	21.6	17.7	18.3	8.8	8.4	9.1	4.9	0.0	4.9	8.3	10.3	3.6	5.8	5.8	8.0	14.3	5.8	8.0	4.3	10.0	9.5	7.9	1.7	10.0	6.5	9.6	6.4	3.6	6.3	14.8	17.3	6.5	6.7	9.6	6.1	13.0	8.7	13.1	7.6	4.7
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45012147-45015575	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Erythroid cells: 607.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		5200000	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	20.7	50.2	23.1	12.2	26.2	67.5	20.7	14.2	28.6	17.7	24.2	16.5	25.9	11.2	27.8	22.6	17.8	20.8	17.4	34.0	21.1	20.3	29.6	58.1	14.3	14.8	21.6	22.9	27.4	18.4	35.9	17.6	25.8	16.2	19.2	12.3	24.3	45.6	19.2	28.8	12.1	13.2	22.9	18.9	16.6	15.0	16.3	11.5	17.2	26.3	23.6	16.0	15.0	13.0	25.7	48.6	20.6	36.3	26.0	27.4	35.6	12.7	8.4	13.4	17.7	23.3	21.9	6.5	15.6	40.4	33.0	25.4	12.1	6.8	9.1	16.6	23.7	23.3	6.6	25.6	30.5	23.0	8.1	26.9	47.0	19.4	39.9	27.1	14.3	8.7	22.7	19.4	31.4	25.5	24.4	42.3	17.6	81.5	10.0	31.4	10.7	9.7	12.4	20.9	10.2	29.7	14.7	20.0	13.1	28.7	10.9	14.4	11.3	17.1	12.9	26.4	15.9	10.1	15.0	27.3	18.8	14.7	6.5	25.2	10.4	11.1	7.6	29.4	21.7	9.4	17.6	36.3	20.6	19.7	25.8	20.0	25.7	23.8	19.2	48.6	23.7	22.3	20.3	6.6	26.0	15.5	32.4	27.4	35.6	23.1	26.2	14.2	28.6	21.1	20.3	21.6	22.9	16.2	11.5	41.7	38.9	45.2	26.1	20.4	23.6	60.9	40.8	22.7	18.2	26.2	15.7	83.3	76.3	62.1	7.2	47.7	22.7	607.3	55.7	45.2	63.6	19.5	50.8	86.0	88.6	12.7	17.2	30.7	34.3	12.5	73.6	37.9	45.5	163.3	18.4	80.8	47.4	21.8	52.6	99.3	21.8	38.8	41.5	35.1	38.5	21.7	41.6	21.8	17.4	22.2
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823248	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		15000	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	13.8	16.1	48.6	9.0	46.6	33.2	13.9	12.8	35.3	8.9	11.4	15.7	12.8	13.2	9.3	41.2	10.5	11.3	11.5	31.4	36.9	20.4	22.6	25.5	10.0	16.8	22.7	23.4	14.5	14.1	14.4	12.0	7.9	20.0	12.9	12.4	14.0	18.1	14.0	45.6	9.8	12.0	13.0	12.5	11.7	12.5	13.8	13.8	10.8	16.4	14.4	12.7	9.4	6.3	17.3	27.1	2.4	15.6	24.7	21.3	17.8	17.7	19.3	14.1	31.2	18.8	19.1	19.0	23.0	39.8	16.2	16.2	8.3	21.6	24.8	10.7	28.5	11.3	10.2	8.1	16.3	15.2	30.6	15.5	52.7	10.9	13.7	26.6	22.2	12.4	23.9	9.4	11.3	30.3	22.5	14.8	18.4	9.1	23.6	27.0	21.2	19.4	25.0	15.3	13.3	20.1	13.8	15.5	14.7	21.2	11.0	11.0	19.0	23.0	17.8	31.2	15.0	15.8	21.2	14.7	21.5	8.0	16.5	19.5	21.8	15.8	16.9	29.9	9.0	10.1	2.4	15.6	2.2	16.1	15.4	18.5	15.7	16.0	20.4	27.1	17.3	21.3	16.3	1.2	24.7	14.6	12.9	14.2	17.8	48.6	46.6	12.8	35.3	36.9	20.4	22.7	23.4	20.0	13.8	17.9	20.2	41.0	10.4	8.2	45.4	60.5	33.1	20.1	17.0	34.9	43.2	49.6	86.2	49.2	45.5	19.3	27.7	186.9	52.4	38.4	25.6	22.0	11.5	53.9	68.9	44.5	13.9	27.6	41.0	95.8	33.1	23.1	59.1	66.7	19.6	51.6	42.5	10.5	38.2	117.1	33.3	6.5	28.2	41.5	71.3	11.2	16.7	38.9	37.7	19.7
